Your browser is no longer supported. Please, upgrade your browser.
Baxter International Inc.
IndexS&P 500 P/E36.46 EPS (ttm)2.13 Insider Own0.20% Shs Outstand509.00M Perf Week-0.96%
Market Cap39.73B Forward P/E19.51 EPS next Y3.98 Insider Trans-4.42% Shs Float504.41M Perf Month-0.42%
Income1.10B PEG4.05 EPS next Q0.64 Inst Own87.10% Short Float1.39% Perf Quarter2.18%
Sales11.67B P/S3.40 EPS this Y37.10% Inst Trans-1.12% Short Ratio2.41 Perf Half Y-7.90%
Book/sh17.07 P/B4.55 EPS next Y17.08% ROA5.60% Target Price92.18 Perf Year-7.81%
Cash/sh7.29 P/C10.65 EPS next 5Y9.00% ROE13.30% 52W Range69.10 - 95.19 Perf YTD-3.18%
Dividend0.98 P/FCF57.91 EPS past 5Y24.40% ROI8.60% 52W High-18.38% Beta0.66
Dividend %1.26% Quick Ratio1.90 Sales past 5Y3.20% Gross Margin39.70% 52W Low12.43% ATR1.60
Employees50000 Current Ratio2.50 Sales Q/Q4.70% Oper. Margin12.50% RSI (14)45.77 Volatility2.09% 2.09%
OptionableYes Debt/Eq0.71 EPS Q/Q181.80% Profit Margin9.40% Rel Volume1.69 Prev Close78.65
ShortableYes LT Debt/Eq0.67 EarningsFeb 04 BMO Payout44.10% Avg Volume2.91M Price77.69
Recom2.10 SMA20-0.04% SMA50-1.84% SMA200-5.24% Volume4,875,383 Change-1.22%
Jan-29-21Downgrade Piper Sandler Overweight → Neutral $100 → $80
Jan-06-21Downgrade UBS Buy → Neutral $95 → $85
Dec-15-20Downgrade Goldman Buy → Neutral $96 → $85
Oct-01-20Upgrade Citigroup Neutral → Buy $94
Sep-04-20Downgrade Argus Buy → Hold
Jun-24-20Initiated Oppenheimer Outperform $100
Mar-19-20Upgrade Stifel Hold → Buy $87 → $95
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $92
Mar-05-20Initiated Citigroup Neutral $94
Feb-13-20Initiated Goldman Buy $104
Jan-02-20Upgrade Evercore ISI In-line → Outperform $80 → $94
Dec-17-19Downgrade Morgan Stanley Overweight → Equal-Weight $90 → $88
Jun-26-19Initiated KeyBanc Capital Markets Sector Weight
Apr-08-19Downgrade Evercore ISI Outperform → In-line
Jan-02-19Upgrade Morgan Stanley Underweight → Overweight
Jan-02-19Upgrade Citigroup Neutral → Buy
Nov-02-18Upgrade Argus Hold → Buy
Oct-16-18Initiated Barclays Underweight $73
May-17-18Resumed Piper Jaffray Overweight $77
Feb-06-18Reiterated Citigroup Neutral $66 → $70
Feb-26-21 05:07PM  
Feb-20-21 02:11AM  
Feb-18-21 01:09AM  
Feb-16-21 04:30PM  
Feb-04-21 07:00PM  
Feb-01-21 09:43AM  
Jan-28-21 12:32PM  
Jan-23-21 01:41AM  
Jan-21-21 04:15PM  
Jan-12-21 09:09AM  
Jan-11-21 08:30AM  
Jan-05-21 04:15PM  
Dec-23-20 11:32PM  
Dec-16-20 04:15PM  
Dec-09-20 11:55AM  
Dec-08-20 05:56PM  
Dec-07-20 08:05AM  
Dec-06-20 11:45AM  
Dec-03-20 08:00AM  
Dec-01-20 03:48PM  
Nov-30-20 01:44PM  
Nov-28-20 01:29AM  
Nov-27-20 12:00AM  
Nov-26-20 07:15AM  
Nov-24-20 08:00AM  
Nov-23-20 08:00AM  
Nov-18-20 04:15PM  
Nov-17-20 04:47PM  
Nov-16-20 04:15PM  
Nov-12-20 08:46AM  
Nov-11-20 08:11AM  
Nov-01-20 07:34AM  
Oct-30-20 03:01AM  
Oct-29-20 10:33AM  
Oct-28-20 09:53AM  
Oct-27-20 09:00AM  
Oct-26-20 07:56AM  
Oct-21-20 06:54PM  
Oct-20-20 08:01AM  
Oct-16-20 03:30AM  
Oct-15-20 04:15PM  
Oct-14-20 08:07AM  
Sep-24-20 08:30AM  
Sep-23-20 08:00AM  
Sep-18-20 06:29AM  
Sep-16-20 09:00AM  
Sep-10-20 06:10PM  
Sep-09-20 06:47PM  
Sep-04-20 11:26AM  
Sep-03-20 08:00PM  
Sep-02-20 05:26PM  
Aug-31-20 02:15PM  
Aug-29-20 11:31AM  
Aug-23-20 08:25AM  
Aug-20-20 04:15PM  
Aug-19-20 06:49PM  
Aug-17-20 06:06AM  
Aug-16-20 02:34AM  
Aug-14-20 05:00PM  
Aug-12-20 09:00AM  
Aug-05-20 08:30AM  
Jul-31-20 09:45AM  
Jul-30-20 06:30PM  
Jul-29-20 09:16AM  
Jul-27-20 10:34AM  
Jul-24-20 08:30AM  
Jul-15-20 08:45AM  
Jul-14-20 08:30AM  
Jul-10-20 04:17PM  
Jul-09-20 04:30PM  
Jul-07-20 02:20PM  
Jun-26-20 12:23PM  
Jun-25-20 09:00AM  
Jun-12-20 08:41PM  
Jun-10-20 08:30AM  
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martin SeanSVP and General CounselNov 02Option Exercise50.7747,0012,386,24186,641Nov 04 04:05 PM
Martin SeanSVP and General CounselNov 02Sale78.6747,0013,697,79439,640Nov 04 04:05 PM
FORSYTH JOHN DDirectorSep 14Option Exercise31.263109,69134,279Sep 15 04:07 PM
FORSYTH JOHN DDirectorSep 14Sale83.5931025,91333,969Sep 15 04:07 PM
GAVIN JAMES R IIIDirectorAug 03Option Exercise38.1414,899568,28954,407Aug 05 05:39 PM
GAVIN JAMES R IIIDirectorAug 03Sale86.4114,8991,287,36639,508Aug 05 05:39 PM
Accogli GiuseppeSVP, President, AmericasJun 19Option Exercise50.2370,7223,552,303138,861Jun 23 04:00 PM
Accogli GiuseppeSVP, President, AmericasJun 19Sale85.0072,3416,148,98566,520Jun 23 04:00 PM
FORSYTH JOHN DDirectorJun 15Option Exercise31.261,50046,89035,398Jun 17 04:02 PM
FORSYTH JOHN DDirectorJun 15Sale82.951,500124,42533,898Jun 17 04:02 PM
Franzi CristianoSVP, President, EMEAJun 08Option Exercise62.2346,6002,899,91885,688Jun 10 04:17 PM
Franzi CristianoSVP, President, EMEAJun 08Sale87.6446,6004,083,87939,088Jun 10 04:17 PM
Frye AndrewSVP, President, APACJun 03Sale91.003,742340,52216,216Jun 05 04:02 PM
Mason Jeanne KSVP, Human ResourcesApr 27Option Exercise28.9747,1461,365,820163,485Apr 29 04:03 PM
Mason Jeanne KSVP, Human ResourcesApr 27Sale93.1347,1464,390,608116,339Apr 29 04:03 PM
HELLMAN PETER SDirectorApr 01Option Exercise24.274,320104,84628,620Apr 03 03:59 PM
STROUCKEN ALBERT P LDirectorApr 01Option Exercise24.274,320104,84634,018Apr 03 04:00 PM
STROUCKEN ALBERT P LDirectorApr 01Sale79.644,320344,02729,698Apr 03 04:00 PM
HELLMAN PETER SDirectorApr 01Sale79.664,320344,14224,300Apr 03 03:59 PM
Martin SeanSVP and General CounselMar 30Buy82.199,780803,81839,504Apr 01 04:17 PM
FORSYTH JOHN DDirectorMar 18Option Exercise31.261,50046,89033,138Mar 19 04:51 PM
FORSYTH JOHN DDirectorMar 18Sale76.701,500115,05031,638Mar 19 04:51 PM